Clinical Trials Sponsored by HCW Biologics

Total 1217 results

Comenius University
NWN & Drink HRW

Completed

Effect of Molecular Hydrogen in Patients With NAFLD (EMoHyNAFLD)

Non-Alcoholic Fatty Liver Disease

Slovakia
Hualan Biological Engineering, Inc.

Completed

Clinical Trial of the Inactivated Influenza Vaccine (0.25ml Formulation for Pediatric Use)

Influenza

China
Hualan Biological Engineering, Inc.

Completed

Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 001

Meningitis
GlaxoSmithKline
Biological E. Limited

Recruiting

Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults

Typhoid Fever

Belgium
Hualan Biological Engineering, Inc.

Completed

Phase IV Clinical Trial of an Inactivated Influenza Split Vaccine

Human Influenza

China
Hualan Biological Engineering, Inc.

Completed

Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003

Meningitis
Hualan Biological Engineering, Inc.

Completed

Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 002

Meningitis
University of Alabama at Birmingham
BioDlogics

Completed

Bone Augmentation Techniques in Extraction Sockets

Tooth Loss

United States
Anewsha Therapeutics Inc.
University of Michigan; Biologics Consulting

Not yet recruiting

(CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC

COVID-19 | SAR

United States
M.D. Anderson Cancer Center
AstraZeneca; Aravive Biologics Inc

Active, not recruiting

AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian Carcinoma | Refractory Fallopian Tube... and other conditions

United States
Lynch Biologics LLC
Medelis Inc.; Centro Medico Militar

Unknown

Evaluation of ABSOLVE in Diabetic Foot Ulcers (ABSOLVE)

Diabetic Foot Ulcers

Guatemala
Prisma Health-Upstate
Clemson University; BioDlogics

Terminated

Amniotic Membrane Allograft Application in the Management of Venous Leg Ulcerations (AmnioExCel)

Venous Insufficiency | Varicose Ulcer

United States
Hualan Biological Engineering, Inc.

Completed

Clinical Trial of Inactivated Influenza Vaccine (0.5ml Formulation)

Influenza

China
Hualan Biological Engineering, Inc.

Completed

Post-marketing Clinical Observation of an Inactivated Influenza Split Vaccine

Human Influenza

China
Solvay Biologicals

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 08/09 Season.

Influenza

Belgium, Germany
Harbin Medical University
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

Study of IBI343 in Subjects With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Sunnybrook Health Sciences Centre
Seagen Inc.; Biocon Biologics

Recruiting

Tucatinib With Brain and/or Spinal XRT in Patients With HER2+ Metastatic Breast Cancer and LMD

HER2-positive Breast Cancer | LMD

Canada
Medtronic Spinal and Biologics
Medtronic Bakken Research Center

Recruiting

The Ailliance Post-Market Clinical Study

Spinal Deformity | Spinal Degenerative Disorder | Spinal Trauma | Spinal Fusion Failure | Spinal Tumor Case

United States
Theriva Biologics, Inc.
Washington University School of Medicine

Recruiting

SYN-004 Safety and Tolerability in Allo-HCT Subjects

121121000119106, Acute Graft-versus-host Reaction Following Bone Marrow Transplant (Disorder)

United States
Shanghai Zhongshan Hospital
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.

Hepatic Carcinoma

China
PT Kalbe Genexine Biologics
Novotech (Australia) Pty Limited

Completed

A Study of Efepoetin Alfa in Treating Anaemia Associated With Chronic Kidney Diseases Patient

Anaemia Associated With Chronic Kidney Disease

Taiwan, Australia, Korea, Republic of, Thailand, Malaysia, Philippines, Indonesia
Chang Gung Memorial Hospital
Medigen Vaccine Biologics Corp.

Active, not recruiting

The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine

COVID-19 | Breakthrough Infection

Taiwan
University of Michigan
BioLogic Engineering, Inc.

Completed

A System for Lengthening Contraction Training of Muscle (LCT)

Healthy

United States
HCA Healthcare Research Institute
Balt USA

Recruiting

Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry (OPTIMA)

Intracranial Aneurysm

United States
Laboratorio Brasileiro de Biologia

Unknown

To Evaluate the Efficacy and Safety Aliviador Compared to Gelol in Patients With Contusions, Sprains, Trauma and Muscle Injury. (LBB-ALI-01/09)

Myalgia | Trauma | Myofascial Pain | Sprains | Contusions | Tendinitis | Muscle Injury

Brazil
Nanyang Technological University
HCA Hospice Care

Unknown

A Novel Mindful-Compassion Art Therapy (MCAT) Supervision (MCAT)

End-of-life Care

Singapore
Sun Yat-sen University
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

PD-1 Antibody and Sapropterin Dihydrochloride in Patients With PDAC

Pancreatic Adenocarcinoma Metastatic

China
Sun Yat-sen University
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

China
M.D. Anderson Cancer Center
Innovent Biologics (Suzhou) Co. Ltd.

Active, not recruiting

Sintilimab in Cancer of Unknown Primary

Cancer of Unknown Primary Site

United States
Laboratorios Richmond S.A.C.I.F.
FP Clinical Pharma S.R.L.; Custom Biologics

Completed

A Clinical Study With Adalimumab Biosimilar

Pharmacokinetics | Safety Issues

Argentina
Medigen Vaccine Biologics Corp.
Coalition for Epidemic Preparedness Innovations

Completed

A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19

COVID-19 Vaccine

Taiwan
Sun Yat-sen University
Innovent Biologics (Suzhou) Co. Ltd.

Active, not recruiting

Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Sun Yat-sen University
Innovent Biologics (Suzhou) Co. Ltd.

Active, not recruiting

Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma (CONTINUUM)

Nasopharyngeal Neoplasms

China
Danielle Kim Turgeon
PvP Biologics, Inc.

Terminated

Gastric Gluten-Degradation Activity of PvP001

Digestive System Disease

United States
Shanghai Institute Of Biological Products

Not yet recruiting

Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma
Suzhou Neologics Bioscience Co., Ltd.

Not yet recruiting

A Dose Escalation and Expansion Study of NB002 in Participants With Advanced or Metastatic Solid Tumors

Advanced Solid Tumor
Shanghai Institute Of Biological Products

Completed

Clinical Trial of Quadrivalent Influenza Virus Split Vaccine

Influenza

China
Shanghai Institute Of Biological Products

Completed

Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 Years

Influenza, Human

China
Shanghai Institute Of Biological Products

Completed

Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live

Vaccine | Immunotoxicity

China
Duke University
Grifols Biologicals, LLC

Completed

Anti-thrombin III (ATIII) vs Placebo in Children (<7mo) Undergoing Open Congenital Cardiac Surgery

ATIII Deficiency

United States
Hualan Biological Bacterin Co. Ltd.

Completed

Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population

Influenza A
Sterna Biologicals GmbH & Co. KG

Completed

Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)

Asthma

Germany
Sterna Biologicals GmbH & Co. KG

Completed

Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma

Asthma

Germany
Sterna Biologicals GmbH & Co. KG

Completed

Safety, Tolerability, and Pharmacokinetics of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects

Asthma

Germany
BSP Biological Signal Processing Ltd.

Unknown

Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry (HyperQ)

Coronary Artery Disease

United States
Shanghai Institute Of Biological Products

Completed

Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants

Influenza

China
Abbott Biologicals
Quintiles, Inc.

Completed

Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived Influenza Vaccine

Influenza

Australia, New Zealand
Abbott Biologicals
Quintiles, Inc.

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2010/2011 Season

Influenza

Belgium, Germany
BSP Biological Signal Processing Ltd.

Unknown

Feasibility of High Frequency QRS Analysis in Patients With Acute Myocardial Infarction

Myocardial Infarction

Israel
China National Center for Cardiovascular Diseases
Innovent Biologics, Inc.

Not yet recruiting

Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population

Acute Coronary Syndrome | Non ST Segment Elevation Acute Coronary Syndrome

Clinical Trials Sponsored by HCW Biologics

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations